Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EARLY-MYO II: Ticagrelor vs Clopidogrel in NSTE-ACS
NCT02201667Phase 4Unknown
- Sponsor
- Renji Hospital
- Start
- Aug 2014
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ticagrelor in acute coronary syndrome (ACS), sponsored by Renji Hospital. Status: unknown.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02201667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02201667.